Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.
Lee
J-H
JH
Cheng
A-L
AL
Lin
C-W
CW
Kuo
S-H
SH
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000187:drug effects; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D016328:NF-kappa B; D013792:Thalidomide